This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|May 2, 2015
- Pharmaceutical Technology-05-02-2015
- Volume 39
- Issue 5
Ross Disperser Increases Versatility
Ross’ HSM-100LH-3 Vacuum High Speed Disperser is designed for up to five gallons of laboratory and pilot-scale mixing.
Ross’ HSM-100LH-3 Vacuum High Speed Disperser is designed for up to five gallons of laboratory and pilot-scale mixing. The disperser can be equipped with a heating/cooling jacket, mixer cover with sight/charge ports, and a vacuum-rated mix vessel. The mixer is designed with interchangeable saw-tooth disperser blades in various sizes including 2-, 3-, 3.5-, and 4-inch diameters, with speeds up to 4800 rpm and turnover of viscosities of up to 50,000 centipoise.
A three horsepower (3HP) variable frequency drive-rated motor operates the mixer, with safety limit switches that prevent operation of the mixer in the raised position or without a mix vessel in place. Single point electrical hook-up is possible with a 3HP inverter that is mounted to the mixer and wired to the motor and limit switches. An air/oil hydraulic lift enables the mixing head to be raised with pushbutton controls.
Ross, Charles & Son Company
Articles in this issue
over 11 years ago
Transdermal Drug Delivery Gains Tractionover 11 years ago
Biomanufacturing Outsourcing Globalization Continuesover 11 years ago
How to Stay Abreast of Shifting Regulations and Remain Compliantover 11 years ago
Considering Continuous Crystallizationover 11 years ago
Fixing Tableting Problemsover 11 years ago
Ensuring the Quality of Biologicalsover 11 years ago
Planning for the Future of Serializationover 11 years ago
Streamlining Raw Materials Testingover 11 years ago
Industry Expert Q&A with Matt Hicksover 11 years ago
UV Laser Marking System Ensures Permanent MarkingRelated to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.